
JangoBio moving closer to commercialization
JangoBio is moving closer to commercialization as animal testing shows promise for the company’s stem cell therapy. “We have, recently, tangible evidence that all of this now works,” said Bill Kohl, chief operating officer for JangoBio. “Before, we had a